EARLY MEROPENEM PHARMACOKINETICS AND TARGET ATTAINMENT IN CHILDREN WITH SEVERE VS NON-SEVERE SEPSIS

被引：0
|
作者：
Paice, K. [1 ]
Girdwood, S. Tang [1 ]
Pavia, K. [1 ]
Mizuno, T. [1 ]
Kaplan, J. [1 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-112
引用
收藏
页码：S86 / S86
页数：1
相关论文
共 50 条
  • [31] THE PHARMACOKINETICS OF MEROPENEM IN SURGICAL PATIENTS WITH MODERATE OR SEVERE INFECTIONS
    LOVERING, AM
    VICKERY, CJ
    WATKIN, DS
    LEAPER, D
    MCMULLIN, CM
    WHITE, LO
    REEVES, DS
    MACGOWAN, AP
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (01) : 165 - 172
  • [32] Hemophilic arthropathy in non-severe hemophiliacs
    Beyan, Cengiz
    Kaptan, Kursat
    Ifran, Ahmet
    RHEUMATOLOGY INTERNATIONAL, 2007, 27 (05) : 501 - 502
  • [33] Hemophilic arthropathy in non-severe hemophiliacs
    Cengiz Beyan
    Kürşat Kaptan
    Ahmet Ifran
    Rheumatology International, 2007, 27 : 501 - 502
  • [34] Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register
    Humphries, Steve E.
    Cooper, Jackie A.
    Capps, Nigel
    Durrington, Paul N.
    Jones, Ben
    McDowell, Ian F. W.
    Soran, Handrean
    Neil, Andrew H. W.
    ATHEROSCLEROSIS, 2019, 281 : 207 - 212
  • [35] Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis
    Hartman, Stan J. F.
    Boeddha, Navin P.
    Ekinci, Ebru
    Koch, Birgit C. P.
    Donders, Rogier
    Hazelzet, Jan A.
    Driessen, Gertjan J.
    de Wildt, Saskia N.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (07) : 1255 - 1260
  • [36] Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis
    Stan J. F. Hartman
    Navin P. Boeddha
    Ebru Ekinci
    Birgit C. P. Koch
    Rogier Donders
    Jan A. Hazelzet
    Gertjan J. Driessen
    Saskia N. de Wildt
    European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 1255 - 1260
  • [37] THE COST OF NON-SEVERE HYPOGLYCAEMIA IN EUROPE
    Chubb, B.
    Tikkanen, C.
    VALUE IN HEALTH, 2015, 18 (07) : A611 - A611
  • [38] INADEQUATE MEROPENEM TARGET ATTAINMENT EARLY IN PEDIATRIC CRITICAL ILLNESS
    Paice, Kelli
    Girdwood, Sonya Tang
    Mizuno, Tomoyuki
    Tang, Peter
    Curry, Calise
    Jones, Rhonda
    Stoneman, Erin
    Yunger, Toni
    Dong, Min
    Vinks, Alexander
    Kaplan, Jennifer
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 499 - 499
  • [39] Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis
    Weiss, KD
    PEDIATRICS, 2004, 113 (01) : 134 - 134
  • [40] Peritoneal Pharmacokinetics and Pharmacodynamic Target Attainment of Meropenem in Patients Undergoing Abdominal Surgery
    Soga, Y.
    Ohge, H.
    Ikawa, K.
    Morikawa, N.
    Ikeda, K.
    Sueda, T.
    JOURNAL OF CHEMOTHERAPY, 2010, 22 (02) : 98 - 102
12345